Vinpocetine is a compound derived from the periwinkle plant, specifically from the Vinca minor species. This synthetic ethyl ester of apovincamine was first discovered in the late 1960s and has since been utilized for its potential cognitive-enhancing and neuroprotective properties. Found naturally in the leaves of the lesser periwinkle, vinpocetine has drawn interest from the scientific community due to its proposed benefits in brain health and function.

As a nootropic, vinpocetine is often classified among supplements that are believed to support cognitive function, enhance memory, and protect the brain against age-related decline. The term "nootropic" itself refers to substances that can boost cognitive abilities, including memory, creativity, and motivation, in healthy individuals. Vinpocetine has garnered attention not only for its potential cognitive benefits but also for its role in promoting healthy blood flow within the brain.

Despite its widespread use and the promising basic science behind it, vinpocetine has not been officially approved by regulatory bodies like the FDA for the treatment of cognitive impairment. However, it is available as a dietary supplement in many countries and continues to be a subject of research for its possible applications in enhancing brain health and mitigating cognitive decline.

Vinpocetine is primarily used as a cognitive enhancer and neuroprotective agent. It is often marketed for its potential to improve memory, increase mental clarity, and support overall brain health. While its use is widespread in certain countries for these purposes, it is important to delve into what the scientific studies say about its efficacy.

Several studies have explored vinpocetine's role in cognitive function, especially in conditions like mild cognitive impairment and dementia. For instance, research published in the Cochrane Database of Systematic Reviews examined the effects of vinpocetine on patients with various forms of dementia, including Alzheimer's disease and vascular dementia. The review found that vinpocetine at doses of 30 mg/day showed potential benefits in improving cognitive impairment, though the number of patients treated for extended periods was relatively small, and the evidence was not conclusive (Szatmári & Whitehouse, 2003).

Animal studies have also provided insight into vinpocetine's mechanisms and effects. A study in the European Journal of Pharmacology reported that vinpocetine improved cognitive function and reduced oxidative stress in a rat model of Alzheimer's disease by modulating cholinergic functions and preventing neuronal damage (Deshmukh et al., 2009). Another animal study published in Behavioural Brain Research demonstrated that vinpocetine could ameliorate learning and memory impairments induced by amyloid-beta peptide in rats, potentially due to its antioxidant properties (Shekarian et al., 2020).

In healthy individuals, vinpocetine has shown mixed results. A study in the European Journal of Clinical Pharmacology reported that while vinpocetine significantly improved memory performance in healthy female volunteers at a dose of 40 mg, it did not produce statistically significant changes in other cognitive tests (Subhan & Hindmarch, 2004).

Overall, while vinpocetine shows promise as a cognitive enhancer and neuroprotective agent, particularly in cases of cognitive impairment and dementia, more large-scale, well-controlled studies are needed to conclusively determine its efficacy and safety.

Vinpocetine operates through multiple mechanisms that collectively contribute to its potential cognitive-enhancing and neuroprotective effects. One of the primary ways vinpocetine works is by increasing cerebral blood flow, which can enhance the delivery of oxygen and nutrients to brain cells. This improved circulation is thought to support cognitive functions such as memory, attention, and overall mental clarity.

At the molecular level, vinpocetine acts as a phosphodiesterase type 1 (PDE1) inhibitor. By inhibiting PDE1, vinpocetine increases the levels of cyclic nucleotides like cAMP and cGMP, which play crucial roles in cellular signaling and neuroplasticity. Enhanced cyclic nucleotide signaling can improve neuronal communication and synaptic plasticity, which are vital for learning and memory processes (Deshmukh et al., 2009).

Another significant mechanism is vinpocetine's antioxidative properties. Oxidative stress, which involves the damaging effects of free radicals on cells, is a contributing factor to cognitive decline and neurodegenerative diseases. Vinpocetine helps mitigate oxidative stress by reducing the levels of oxidative markers such as malondialdehyde (MDA) and nitrite, while also restoring antioxidant levels like reduced glutathione (GSH). This antioxidative action helps protect neurons from damage, thereby preserving cognitive function (Shekarian et al., 2020).

Vinpocetine also exhibits anti-inflammatory effects. Chronic inflammation in the brain is another contributing factor to neurodegenerative conditions. Vinpocetine has been shown to reduce the levels of pro-inflammatory cytokines like tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β), while increasing anti-inflammatory markers like interleukin-10 (IL-10). This anti-inflammatory action contributes to a healthier brain environment, which supports cognitive functions and potentially slows down cognitive decline (Ibrahim et al., 2022).

In summary, vinpocetine's multifaceted mechanisms—including enhancing cerebral blood flow, inhibiting phosphodiesterase, providing antioxidative protection, and exerting anti-inflammatory effects—collectively contribute to its potential cognitive-enhancing and neuroprotective benefits.

The use of vinpocetine in men’s and women’s health primarily focuses on its cognitive-enhancing properties, and there is limited evidence to suggest significant gender-specific differences in its efficacy or application. However, some nuances exist in how vinpocetine may be perceived and tolerated between genders, which are worth noting.

In general, vinpocetine is utilized by both men and women to support cognitive function, enhance memory, and protect against cognitive decline. Studies have demonstrated its potential benefits in a variety of populations, including elderly individuals with mild cognitive impairment and those experiencing age-related cognitive decline. For instance, a study published in the European Journal of Clinical Pharmacology found that vinpocetine improved memory performance in healthy female volunteers at a dose of 40 mg (Subhan & Hindmarch, 2004). However, this study did not specifically compare these effects to those in men, highlighting a gap in gender-specific research.

When considering gender differences, it is important to take into account hormonal variations, especially in women. Hormonal changes during menstrual cycles, pregnancy, and menopause can influence brain function and cognitive performance. While there is no direct evidence indicating that vinpocetine interacts with these hormonal fluctuations, it is plausible that women might experience variable effects due to these physiological changes. More research is needed to explore this potential interaction and its implications for women’s health.

In terms of safety and tolerance, both men and women generally report similar experiences with vinpocetine. Clinical trials have shown that vinpocetine is well-tolerated with few adverse effects, and these outcomes appear consistent across genders. For example, a study published in the Journal of the American Geriatrics Society reported no significant side effects in elderly patients, irrespective of gender, who were treated with vinpocetine for chronic cerebral dysfunction (Balestreri et al., 1987).

Overall, while there is no substantial evidence to suggest that vinpocetine is used differently between men and women, individual responses may vary based on physiological and hormonal factors. Further research is needed to better understand any potential gender-specific effects and optimize its use in both men’s and women’s health.

The appropriate dosage of vinpocetine can vary depending on the intended use, individual health conditions, and specific product formulations. Generally, dosages used in studies and clinical trials range from 5 mg to 60 mg per day, divided into smaller doses taken throughout the day. However, the most commonly studied and recommended dosages tend to fall between 15 mg and 30 mg per day.

For cognitive enhancement and support, a typical starting dose is often around 5 mg taken three times daily, totaling 15 mg per day. Some studies have used higher doses, such as 10 mg taken three times daily (30 mg per day), to evaluate the efficacy and safety of vinpocetine in improving cognitive function. For instance, research published in the Cochrane Database of Systematic Reviews indicated potential benefits at 30 mg/day and 60 mg/day in patients with cognitive impairment (Szatmári & Whitehouse, 2003).

In cases where vinpocetine is being used to support brain health in individuals with mild cognitive impairment or age-related cognitive decline, higher doses may be employed. For example, studies involving elderly patients with chronic cerebral dysfunction have used dosages up to 60 mg per day, divided into three doses of 20 mg each, over extended periods (Balestreri et al., 1987).

It is essential to note that while higher doses may offer increased benefits, they should be approached with caution and under professional guidance. The body of evidence suggests that vinpocetine is generally well-tolerated, but individual responses can vary, and higher doses may increase the risk of mild side effects.

Ultimately, the optimal dosage of vinpocetine should be tailored to individual needs and conditions. Starting with a lower dose and gradually increasing it while monitoring for any adverse effects is a prudent approach. Consulting with a healthcare professional can provide personalized recommendations and ensure the safe and effective use of vinpocetine.

Vinpocetine is generally well-tolerated, but like any supplement, it can have side effects. The majority of reported side effects are mild and transient. Some of the most commonly noted side effects include gastrointestinal disturbances, such as nausea, stomach pain, or indigestion. These symptoms are usually mild and often resolve without the need for medical intervention.

Headaches and dizziness are also among the more frequently reported side effects. These symptoms may occur as the body adjusts to the supplement and typically diminish over time. In clinical trials, such as the one published in the Journal of the American Geriatrics Society, participants did not report significant adverse effects, suggesting that vinpocetine's side effects are generally manageable (Balestreri et al., 1987).

In some cases, vinpocetine may cause sleep disturbances or insomnia, particularly if taken later in the day. This is likely due to its potential stimulating effects on brain function. To mitigate this, it is often recommended to take vinpocetine earlier in the day and avoid late-afternoon or evening doses.

Less common side effects can include flushing, dry mouth, and transient hypotension (low blood pressure). These are typically mild and do not require discontinuation of the supplement. However, individuals who experience persistent or bothersome symptoms should consult with a healthcare provider to discuss their concerns and consider adjusting the dosage.

Overall, while vinpocetine is considered safe for most people when taken at recommended doses, individual responses can vary. Monitoring for side effects and communicating with a healthcare professional can help ensure a safe and positive experience with vinpocetine.

While vinpocetine is generally considered safe for most people, there are certain groups of individuals who should exercise caution or avoid taking this supplement altogether.

Firstly, pregnant and breastfeeding women are advised against using vinpocetine. There is insufficient research on the safety of vinpocetine for unborn babies and infants, which makes it prudent to avoid its use during pregnancy and lactation.

Individuals with a history of low blood pressure (hypotension) should also be cautious. Vinpocetine has been noted to cause transient hypotension in some cases, and for those already prone to low blood pressure, this effect could exacerbate their condition. Consulting with a healthcare provider is essential before starting vinpocetine in such scenarios.

People with bleeding disorders or those taking anticoagulant or antiplatelet medications should avoid vinpocetine. Vinpocetine may have a mild blood-thinning effect, which could increase the risk of bleeding, particularly when combined with other blood-thinning agents. Medications such as warfarin, aspirin, and other anticoagulants or antiplatelet drugs could potentially interact with vinpocetine, leading to heightened bleeding risks.

Additionally, individuals with a history of seizures or epilepsy should exercise caution. Although some studies have explored vinpocetine's effects in epilepsy, its safety profile in individuals with seizure disorders is not well established. Consulting with a neurologist or healthcare provider is crucial for anyone with a history of seizures considering vinpocetine.

Lastly, anyone with known allergies to periwinkle plants or related compounds should avoid vinpocetine to prevent allergic reactions. As with any supplement, individuals with complex medical conditions or those taking multiple medications should always consult with a healthcare provider before starting vinpocetine to ensure it is safe and appropriate for their specific health needs.

Yes, vinpocetine supplements are known to interact with certain medications, and these interactions can potentially affect the efficacy of the medications or lead to adverse effects. It is important to be aware of these interactions and consult with a healthcare provider before starting vinpocetine, especially if you are taking other medications.

One of the primary concerns with vinpocetine is its potential interaction with blood-thinning medications. Vinpocetine has been observed to have a mild anticoagulant effect, which can enhance the effects of other blood-thinning agents. This can increase the risk of bleeding. Medications such as warfarin, aspirin, clopidogrel, and other anticoagulants or antiplatelet drugs are particularly noteworthy in this regard. If you are taking any of these medications, it is crucial to consult your healthcare provider to determine whether vinpocetine is safe for you.

Vinpocetine may also interact with medications that lower blood pressure. Since vinpocetine has been noted to cause transient hypotension in some cases, combining it with antihypertensive medications could potentially lead to an excessive drop in blood pressure. Medications such as beta-blockers, ACE inhibitors, calcium channel blockers, and diuretics fall into this category. Monitoring your blood pressure and consulting your healthcare provider can help manage any potential risks.

Individuals taking medications for seizure disorders should exercise caution as well. Although vinpocetine has been studied for its effects on epilepsy, the results are not conclusive, and its interaction with anticonvulsant medications remains uncertain. It is essential to discuss with a neurologist or healthcare provider if you have a history of seizures and are considering vinpocetine.

Additionally, vinpocetine may interact with medications metabolized by the liver, particularly those processed by the cytochrome P450 enzyme system. While specific interactions with vinpocetine have not been extensively studied, it is generally advisable to be cautious with any supplement that could potentially affect liver enzyme activity.

In summary, vinpocetine supplements can interact with blood-thinning medications, antihypertensive drugs, anticonvulsants, and potentially other medications metabolized by the liver. Consulting with a healthcare provider is essential to ensure that vinpocetine is safe and appropriate for your individual health needs, especially if you are taking any other medications.

When it comes to sourcing vinpocetine supplements, it's important to choose products from reputable manufacturers and trusted retailers. The quality, purity, and potency of vinpocetine supplements can vary significantly between brands, so selecting a reliable source is crucial for ensuring effectiveness and safety. Here are some key considerations for finding the best sources of vinpocetine:

1. Reputable Brands: Look for well-known, established brands that have a good track record in the supplement industry. Companies that have been around for a while and have positive reviews are more likely to adhere to high-quality manufacturing standards. Brands that invest in research and development and have transparency in their ingredient sourcing and manufacturing processes are often more reliable.
2. Third-Party Testing: Choose supplements that have been third-party tested for quality and purity. Third-party testing ensures that the product contains the ingredients listed on the label and is free from contaminants such as heavy metals, pesticides, and microbial impurities. Look for certifications or seals from independent testing organizations on the product packaging.
3. Good Manufacturing Practices (GMP) Certification: Products manufactured in facilities that follow Good Manufacturing Practices (GMP) standards are more likely to be of high quality. GMP certification indicates that the manufacturer adheres to stringent guidelines for production, quality control, and testing.
4. Transparent Labeling: The supplement label should clearly list the amount of vinpocetine per serving, along with any other ingredients present in the product. Avoid supplements with proprietary blends that do not disclose the specific dosage of each ingredient. Transparent labeling helps you understand exactly what you are consuming.
5. Customer Reviews and Recommendations: Reading customer reviews and seeking recommendations from healthcare professionals or trusted sources can provide valuable insights into the effectiveness and quality of a vinpocetine supplement. Look for reviews that mention improvements in cognitive function, memory, and overall well-being.
6. Natural Health Food Stores and Pharmacies: Purchasing vinpocetine from reputable health food stores, pharmacies, or online retailers known for their commitment to quality can be a good option. These retailers often carry products from reputable brands and may have knowledgeable staff who can provide guidance.

By considering these factors and doing your research, you can find high-quality vinpocetine supplements that are effective and safe. Always consult with a healthcare professional before starting any new supplement regimen to ensure it is appropriate for your individual health needs.

Vinpocetine is available in several forms, offering flexibility and convenience for individuals seeking to incorporate it into their health regimen. The most common forms of vinpocetine supplements include:

1. Capsules: Vinpocetine capsules are one of the most popular forms available. They typically contain a specific dose of vinpocetine, such as 5 mg, 10 mg, or 20 mg per capsule, making it easy to manage and adjust the dosage as needed. Capsules are convenient to take and are often preferred by those who want a quick and easy way to consume their supplements.
2. Tablets: Similar to capsules, vinpocetine tablets provide a precise dosage of the compound. They are available in various strengths and are designed to be swallowed with water. Tablets can sometimes be split or crushed if a lower dose is required, but this should be done following the manufacturer’s guidelines or under the advice of a healthcare professional.
3. Liquid Extracts: Vinpocetine liquid extracts offer an alternative for individuals who may have difficulty swallowing capsules or tablets. These extracts can be added to water, juice, or another beverage, providing flexibility in how they are consumed. Liquid forms often allow for more precise dosage adjustments and may be absorbed more quickly by the body.
4. Powder: Vinpocetine powder is another form that can be mixed into drinks or food. This form provides the versatility of adjusting the dosage easily and can be incorporated into various recipes or smoothies. However, measuring the correct dosage requires precision and care.
5. Softgels: Softgel capsules contain vinpocetine in a liquid or semi-liquid form within a gelatin shell. They are easy to swallow and may offer better absorption compared to traditional capsules or tablets. Softgels are a convenient option for those who prefer a smoother texture.
6. Chewable Tablets: Although less common, vinpocetine is also available in chewable tablet form. These are designed to be chewed before swallowing and can be a good option for individuals who have difficulty swallowing pills. Chewable tablets may come in various flavors to enhance the taste.

Each form of vinpocetine has its own advantages and may be chosen based on personal preference, convenience, and specific health needs. Regardless of the form, it is important to follow the recommended dosage instructions provided by the manufacturer or a healthcare professional to ensure safe and effective use. Consulting with a healthcare provider before starting vinpocetine can help determine the best form and dosage for your individual circumstances.

Vinpocetine itself is a single, well-defined synthetic compound derived from the natural alkaloid vincamine, which is found in the Vinca minor (lesser periwinkle) plant. As such, vinpocetine does not have sub-compounds in the way that herbal extracts might contain multiple active ingredients. Instead, its efficacy is primarily attributed to the vinpocetine molecule itself.

The vinpocetine molecule, chemically known as ethyl apovincaminate, has been extensively studied for its various pharmacological properties. These include its ability to inhibit phosphodiesterase type 1 (PDE1), enhance cerebral blood flow, and exert antioxidant and anti-inflammatory effects. These mechanisms collectively contribute to vinpocetine's potential cognitive-enhancing and neuroprotective benefits.

While vinpocetine does not break down into active sub-compounds, its metabolite apovincaminic acid (AVA) is sometimes discussed in the context of pharmacokinetics and the overall activity profile of vinpocetine. Studies have shown that apovincaminic acid is a primary metabolite of vinpocetine and may contribute to its pharmacological effects. However, the majority of vinpocetine's efficacy is attributed to the parent compound rather than its metabolites.

Research has primarily focused on the vinpocetine molecule itself rather than any sub-compounds or breakdown products. For example, studies published in reputable journals such as the European Journal of Pharmacology and Behavioural Brain Research have investigated vinpocetine's effects on cognitive function, oxidative stress, and neuroprotection, with the findings largely linked to the intact vinpocetine molecule (Deshmukh et al., 2009; Shekarian et al., 2020).

In summary, the critical efficacy of vinpocetine is directly tied to the vinpocetine molecule. Its pharmacological actions are well-documented and are responsible for its potential benefits in cognitive enhancement and neuroprotection. While metabolites like apovincaminic acid may play a role in its overall activity profile, the primary focus remains on the vinpocetine compound itself.

Vinpocetine is known by several names, including its chemical names, brand names, and common misspellings. Here are some of the various names and terms associated with vinpocetine:

1. Chemical Names:
   • Ethyl apovincaminate
   • Ethyl apovincaminate 18-oxide
2. Brand Names:
   • Cavinton
   • Cavinton Forte
   • Intelectol
3. Common Misspellings and Abbreviations:
   • Vinpocetine (correct spelling)
   • Vinpocetin (common misspelling)
   • Vinpocetinic acid (incorrect term but sometimes seen)
   • Vinpotin (abbreviation or misspelling)
4. Related Compounds:
   • Vincamine: The natural alkaloid from which vinpocetine is derived.
   • Apovincamine: Another derivative of vincamine, closely related to vinpocetine.
   • Apovincaminic acid: A primary metabolite of vinpocetine.
5. Other Names and Ingredients:
   • Vinca minor extract: The plant source of vincamine, from which vinpocetine is synthesized.
   • Lesser periwinkle extract: Another term for the source plant, Vinca minor.

Knowing these names and terms can help in identifying vinpocetine in various contexts, whether you're looking at product labels, scientific literature, or discussing it with healthcare providers. It's essential to be aware of these different names to avoid confusion and ensure you are getting the correct supplement.

When selecting a vinpocetine supplement, it's crucial to carefully examine the product label to ensure quality, purity, and potency. Here are several key factors to look for on the label:

1. Active Ingredient and Dosage:
   • Ensure that the label clearly lists "vinpocetine" as the active ingredient.
   • Check the dosage per serving, which typically ranges from 5 mg to 20 mg. Confirm that the dosage aligns with your needs and any recommendations from your healthcare provider.
2. Purity and Additives:
   • Look for information about the purity of the vinpocetine used in the supplement.
   • Check for the presence of any fillers, binders, or artificial additives. High-quality supplements should minimize unnecessary additives and use natural excipients when necessary.
3. Third-Party Testing and Certification:
   • Seek out products that have been independently tested by third-party organizations for quality and purity. Certifications from reputable third-party testers, such as NSF International, USP (United States Pharmacopeia), or ConsumerLab, indicate that the supplement meets high standards.
   • Look for seals or statements on the label indicating third-party testing.
4. Good Manufacturing Practices (GMP) Certification:
   • Ensure the product is manufactured in a facility that follows Good Manufacturing Practices (GMP). GMP certification ensures that the product is produced under stringent quality control standards.
   • This information is often indicated on the label or the manufacturer's website.
5. Expiration Date and Batch Number:
   • Check the expiration date to ensure the product is fresh and effective.
   • The batch number can be useful for tracking and quality control purposes.
6. Manufacturer Information:
   • Look for the manufacturer's name and contact information on the label. Reputable companies are transparent about their contact details and are available to answer consumer questions.
   • Research the manufacturer to ensure they have a good reputation and track record in the supplement industry.
7. Serving Size and Instructions:
   • Review the serving size and recommended usage instructions. This information helps you understand how to take the supplement correctly to achieve the desired effects.
   • Follow the dosage recommendations provided unless advised otherwise by a healthcare professional.
8. Potential Allergens:
   • Check for any allergen information, especially if you have known allergies. The label should disclose whether the supplement is free from common allergens such as gluten, soy, dairy, and nuts.
9. Supplement Facts Panel:
   • The Supplement Facts panel should provide detailed information about the active ingredient (vinpocetine) and other ingredients present in the product.
   • This panel helps you understand the composition and ensures transparency in the formulation.

By thoroughly examining these aspects on the label, you can make an informed decision and choose a high-quality vinpocetine supplement that meets your needs and safety standards. Always consult with a healthcare professional before starting any new supplement regimen to ensure it is appropriate for your individual health circumstances.

The information provided on this website, including any text, images, or other material contained within, is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. This page was created by the SuppCo editiorial team, with AI summarization tools, including data from but not limited to following studies:

1. S. Szatmári, Peter J. Whitehouse (2003). Vinpocetine for cognitive impairment and dementia.. The Cochrane database of systematic reviews, 1,
   CD003119 . Link: 10.1002/14651858.CD003119
2. R. Deshmukh, V. Sharma, Sidharth Mehan, Nidhi Sharma, K. Bedi (2009). Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor.. European journal of pharmacology, 620 1-3,
   49-56 . Link: 10.1016/j.ejphar.2009.08.027
3. L. Thal, D. Salmon, B. Lasker, D. Bower, M. Klauber (1989). The Safety and Lack of Efficacy of Vinpocetine in Alzheimer's Disease. Journal of the American Geriatrics Society, 37, . Link: 10.1111/j.1532-5415.1989.tb05682.x
4. Meysam Shekarian, A. Komaki, S. Shahidi, A. Sarihi, I. Salehi, Safoura Raoufi (2020). The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of amyloid beta (aβ) peptide. Behavioural Brain Research, 383, . Link: 10.1016/j.bbr.2020.112512
5. M. McDaniel, S. Maier, G. Einstein (2003). "Brain-specific" nutrients: a memory cure?. Nutrition, 19 11-12,
   957-75 . Link: 10.1016/S0899-9007(03)00024-8
6. A. Valikovics, A. Csányi, L. Németh (2012). [Study of the effects of vinpocetin on cognitive functions].. Ideggyogyaszati szemle, 65 3-4,
   115-20 . Link:
7. Surbhi Gupta, Prabhat K. Singh, B. Sharma, Bhupesh Sharma (2015). Neuroprotective Effects of Agomelatine and Vinpocetine Against Chronic Cerebral Hypoperfusion Induced Vascular Dementia.. Current neurovascular research, 12 3,
   240-52 . Link: 10.2174/1567202612666150603130235
8. Rania I Nadeem, Hebatalla I. Ahmed, B. El‐Sayeh (2018). Protective effect of vinpocetine against neurotoxicity of manganese in adult male rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 391, 729 - 742. Link: 10.1007/s00210-018-1498-0
9. Y. Shang, Lei Wang, Yüe Li, Pei-fei Gu (2016). Vinpocetine Improves Scopolamine Induced Learning and Memory Dysfunction in C57 BL/6J Mice.. Biological & pharmaceutical bulletin, 39 9,
   1412-8 . Link: 10.1248/bpb.b15-00881
10. Patricia C. Swart, C. Currin, V. Russell, J. Dimatelis (2017). Early ethanol exposure and vinpocetine treatment alter learning‐ and memory‐related proteins in the rat hippocampus and prefrontal cortex. Journal of Neuroscience Research, 95, . Link: 10.1002/jnr.23894
11. Z. Subhan, I. Hindmarch (2004). Psychopharmacological effects of vinpocetine in normal healthy volunteers. European Journal of Clinical Pharmacology, 28, 567-571. Link: 10.1007/BF00544068
12. D. Bereczki, I. Fekete (2008). Vinpocetine for acute ischaemic stroke.. The Cochrane database of systematic reviews, 1,
    CD000480 . Link: 10.1002/14651858.CD000480.pub2
13. R. Deshmukh, V. Sharma, Sidharth Mehan, Nidhi Sharma, K. Bedi (2009). Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor.. European journal of pharmacology, 620 1-3,
    49-56 . Link: 10.1016/j.ejphar.2009.08.027
14. K. Meador, B. Leeman-Markowski, A. Medina, Sílvia M. Illamola, J. Seliger, G. Novak, Christine Lin, M. Ivanisevic, B. Razavi, S. Marino, A. Boyd, D. Loring (2021). Vinpocetine, cognition, and epilepsy. Epilepsy & Behavior, 119, . Link: 10.1016/j.yebeh.2021.107988
15. Meysam Shekarian, A. Komaki, S. Shahidi, A. Sarihi, I. Salehi, Safoura Raoufi (2020). The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of amyloid beta (aβ) peptide. Behavioural Brain Research, 383, . Link: 10.1016/j.bbr.2020.112512
16. Yishuai Zhang, Jian-Dong Li, C. Yan (2018). An update on vinpocetine: New discoveries and clinical implications. European Journal of Pharmacology, 819, 30–34. Link: 10.1016/j.ejphar.2017.11.041
17. I. Hindmarch, Hans-Hermann Fuchs, H. Erzigkeit (1991). Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes.. International clinical psychopharmacology, 6 1,
    31-43 . Link: 10.1097/00004850-199100610-00005
18. MA Ibrahim, Wameedh H. Abbas, Muhsin Sagheer Ghalib, N. Al-Shawi (2022). Neuroprotective Effect of Vinpocetine against Lead Acetate-Instigated Neurotoxicity in Rats by Evaluation Tumor Necrosis Factor-Alpha, Interleukin-1Beta and Interleukin-10. Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512), , . Link: 10.31351/vol31iss2pp129-134
19. R. Balestreri, L. Fontana, F. Astengo (1987). A Double‐Blind Placebo Controlled Evaluation of the Safety and Efficacy of Vinpocetine in the Treatment of Patients with Chronic Vascular Senile Cerebral Dysfunction. Journal of the American Geriatrics Society, 35, . Link: 10.1111/j.1532-5415.1987.tb04664.x
20. S. Szatmári, Peter J. Whitehouse (2003). Vinpocetine for cognitive impairment and dementia.. The Cochrane database of systematic reviews, 1,
    CD003119 . Link: 10.1002/14651858.CD003119